On January 31, 2024, Fate Therapeutics (FATE) had a market capitalization of $622.8M, based on 101.1M shares at a price of $6.16.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
January 31 2024 21:00 | $6.16 | — | 101,104,300 | $622,802,488.00 |
January 31 2024 20:30 | $6.16 | 1,485,117 | 101,104,300 | $622,802,488.00 |
January 31 2024 19:30 | $6.35 | 2,088,473 | 101,104,300 | $642,012,305.00 |
January 31 2024 18:30 | $6.13 | 949,192 | 101,104,300 | $619,263,837.50 |
January 31 2024 17:30 | $5.91 | 333,452 | 101,104,300 | $597,779,173.75 |
January 31 2024 16:30 | $5.90 | 364,140 | 101,104,300 | $596,909,676.77 |
January 31 2024 15:30 | $5.84 | 598,527 | 101,104,300 | $589,943,590.50 |
January 31 2024 14:30 | $5.87 | 655,240 | 101,104,300 | $592,976,719.50 |
